Tuesday, October 18, 2011
12:30 pm–2:00 pm
Organized by the Student Postdoc and Outreach Development Committee
Conducted by Steven Hansel, Ph.D., Pfizer
Moderated by Sam Gilchrist, The University of British Columbia
About the webinar
The intent of the webinar is to provide an overview of the Drug Development process and to increase awareness of career opportunities in the pharmaceutical sciences to students studying Chemistry, Biology, and Engineering (CBE). There is currently an unmet need for an “educational toolkit” of the drug development process to support this type of educational outreach. This webinar is part of a group of activities for CBE students. The CBE subcommittee under the SPOD Committee began during past-president Danny Shen’s directive to outreach to this audience. Therefore, AAPS members are NOT the primary audience and as a result, the webinar needs to be public (not behind the member firewall). This webinar would need to be promoted through National Science Teachers Association, National School Counselors Association and even mentioned at the science and engineering fair (it will be archived by then).
Explore how pharmaceutical companies turn a chemical substance into a marketed drug. A pharmaceutical scientist will guide you through the drug’s journey from the lab to your medicine cabinet and where you could fit in. You will also learn how Chemistry, Biology, and Engineering are involved in the various phases of the process which could provide you with a challenging and rewarding career in the future.
Drug Development Basics
- Brief Introduction
- Drug Discovery
- Regulatory/Post Marketing Surveillance
About the Presenter
Steven Hansel, Ph.D. is a senior director in the Department of Pharmacokinetics, Dynamics, and Metabolism (PDM) at Pfizer Inc. located at the Groton, Conn. research site. His teams provide preclinical modeling and simulation support, biomarker development and bioanalysis, and biotherapeutics PK support to the oncology, cardiovascular, and neurosciences therapeutic areas. He previously served as PDM leader to the Cardiovascular as well as Antibacterial Research Units in Groton and formerly led the PDM Inflammation unit based in Ann Arbor, Mich. He spent the first decade of his career in small molecule drug discovery research at Bristol-Myers Squibb working primarily in the oncology, neuroscience, and antiviral therapeutic areas. Hansel received a B.S. in pharmacy from the Albany College of Pharmacy and Ph.D. in pharmaceutics from SUNY Buffalo.